Close
American Drug Delivery & Formulation Summit
Xylem

Virginia adopts national precursor log exchange system

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Digital Health Tools Are Transforming Patient Care Models

The integration of advanced technology into the clinical environment...

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.
- Advertisement -

The commonwealth of Virginia has adopted a real-time, stop-sale technology known as national precursor log exchange system.

NPLEx targets methamphetamine criminals, while protects law-abiding consumers’ access to safe and effective medicines containing pseudoephedrine (PSE) including Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed.ย NPLEx provides a secure, interconnected electronic logbook that tracks and logs every PSE sale in every store at the moment it is happening.

The system also provides law enforcement officials with a new and effective tool in the fight against meth and can block the illegal sale in real-time and across state lines.ย Consumer Healthcare Products Association president and chief executive officer Scott Melville said the company applaud Gov. McDonnell, Senators Lucas and Stuart, the Virginia legislature, and Virginia law enforcement for implementing a proven solution that will fight domestic meth production while maintaining consumer access to widely used cold and allergy medicines.

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Digital Health Tools Are Transforming Patient Care Models

The integration of advanced technology into the clinical environment...

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.

Digital Therapeutics Expanding Pharmaceutical Care

Redefining patient treatment through clinically validated software interventions that complement or replace traditional medications, offering personalized, remote, and scalable care for chronic conditions.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป